PAR-22-200 - Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 3

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs) NOT-DA-25-032 NIDA , NCCIH Nov 25, 2024 Jan 8, 2029 R01, UG3/UH3, U01, R21
Notice of Special Interest (NOSI): HEAL Initiative: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose NOT-DA-23-010 NIDA Sep 28, 2022 Sep 2, 2025 UG3/UH3

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders NOT-DA-22-049 NIDA Dec 22, 2021 Sep 2, 2022 UG3/UH3
For technical issues E-mail OER Webmaster